Skip to main content
Clinical Trials/NCT03197948
NCT03197948
Terminated
N/A

A Pilot Feasibility Trial Examining the Use of Electronic Patient-Reported Outcomes in Prostate Cancer Patients With Apple ResearchKit Smartphone Application

Sidney Kimmel Cancer Center at Thomas Jefferson University1 site in 1 country20 target enrollmentJuly 28, 2016
ConditionsProstate

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prostate
Sponsor
Sidney Kimmel Cancer Center at Thomas Jefferson University
Enrollment
20
Locations
1
Primary Endpoint
Feasibility defined as satisfactory completion (60%) of weekly questionnaires
Status
Terminated
Last Updated
last year

Overview

Brief Summary

This pilot clinical trial studies how well electronic patient reported outcomes work in measuring health-related quality of life in patients with stage I-IV prostate cancer undergoing treatment. Using a smartphone application to measure and monitor symptoms before, during, and after treatment may help patients better detect, understand, and manage their health.

Detailed Description

PRIMARY OBJECTIVES: I. To explore the feasibility of collecting electronic patient-reported outcome data using validated health-related quality of life (HRQOL) assessment tools at baseline, during, and after treatment through a smartphone application in adult men throughout their course of treatment for prostate cancer.

Registry
clinicaltrials.gov
Start Date
July 28, 2016
End Date
June 8, 2018
Last Updated
last year
Study Type
Observational
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Self-reported ability to speak and read English
  • Be able to communicate on a touch screen iPhone
  • Willing to provide signed informed consent
  • Willing and able to comply with all study activities
  • Access to WiFi connection or cellular data
  • An established clinical history of prostate cancer in a spectrum of severity (all stages)

Exclusion Criteria

  • A subject will not be eligible for inclusion in this study if in the investigator's opinion the patient has any concurrent medical or psychiatric condition that may preclude participation in this study or completion of self-administered questionnaires (e.g., moderate to severe dementia and/or severe, uncontrolled schizophrenia, or other condition that would render them unable to complete a questionnaire)
  • Cognitive or other impairment (e.g., visual) that would interfere with completing a self- administered questionnaire and with participating in a group discussion

Outcomes

Primary Outcomes

Feasibility defined as satisfactory completion (60%) of weekly questionnaires

Time Frame: Up to 3 months

The rate of satisfactory completion will be estimated along with a one-sided exact 95% confidence interval. The method will be considered feasible if the lower bound of the confidence interval is above 0.7 or, equivalently, if at least 49/60 (82%) of participants have satisfactory completion. Rates of completion may be estimated by levels of baseline demographic or clinical characteristics.

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
N/A
RAPID AFib Decision Aid for Stroke Prevention in Atrial FibrillationAtrial Fibrillation
NCT05900414University of Calgary60
Completed
N/A
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryStage I Adult Liver CancerStage I Colorectal CancerStage IA Gastric CancerStage IA Pancreatic CancerStage IB Gastric CancerStage IB Pancreatic CancerStage II Adult Liver CancerStage IIA Colorectal CancerStage IIA Gastric CancerStage IIA Pancreatic CancerStage IIB Colorectal CancerStage IIB Gastric CancerStage IIB Pancreatic CancerStage IIC Colorectal CancerStage III Pancreatic CancerStage IIIA Adult Liver CancerStage IIIA Colorectal CancerStage IIIA Gastric CancerStage IIIB Adult Liver CancerStage IIIB Colorectal CancerStage IIIB Gastric CancerStage IIIC Adult Liver CancerStage IIIC Colorectal CancerStage IIIC Gastric CancerStage IV Gastric CancerStage IVA Colorectal CancerStage IVA Liver CancerStage IVA Pancreatic CancerStage IVB Colorectal CancerStage IVB Liver CancerStage IVB Pancreatic Cancer
NCT02511821City of Hope Medical Center22
Completed
N/A
Feasibility Study of an ePRO Monitoring for Patients With Multiple Myeloma and Development of Item ListsMultiple Myeloma
NCT05036863Medical University Innsbruck39
Completed
N/A
A Pilot Study of eHealth Tools in a Tertiary-care SettingDepression
NCT03762460University of British Columbia60
Active, Not Recruiting
N/A
Symptom Management in Patients on DialysisEnd-stage Kidney Disease
NCT05515991University Health Network, Toronto36